Can faster chemo beat tough breast cancer? new trial aims to find out
NCT ID NCT05728268
First seen Jan 11, 2026 · Last updated May 21, 2026 · Updated 25 times
Summary
This study tests whether giving chemotherapy more frequently (dose-dense) works better for people with a common type of breast cancer (HR+/HER2-) that grows quickly. The trial will enroll 64 women with high-risk, early-stage breast cancer to see if this approach reduces tumor burden more effectively. Researchers will also look for genetic markers to predict who benefits most.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shantou Central Hospital
RECRUITINGShantou, Guangdong, 510000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.